Trial of a Novel Fibrinolytic (Alfimeprase) to Clear Thrombosed Vascular

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double-Blind, Primary Purpose: Treatment

Related Conditions & MeSH terms

Catheters, Indwelling

See also
Status	Clinical Trial	Phase
Withdrawn	`NCT00785252` - EZIO Compared to Central Venous Lines for Emergency Vascular Access	N/A
Completed	`NCT03351725` - Peripheral Venous Catheter Colonization Study
Completed	`NCT00272623` - Seldinger Technique Versus Venous Cut-Down for Placement of Totally Implantable Venous Access Ports	N/A
Completed	`NCT00001518` - A Randomized Evaluation of the Effect of Routine Normal Saline Flush Versus Heparinized Saline Solution in Groshong and Groshong PICC Catheters	N/A

See also

Status

Clinical Trial

Phase

Withdrawn

NCT00785252 - EZIO Compared to Central Venous Lines for Emergency Vascular Access

N/A

Completed

NCT03351725 - Peripheral Venous Catheter Colonization Study

Completed

NCT00272623 - Seldinger Technique Versus Venous Cut-Down for Placement of Totally Implantable Venous Access Ports

N/A

Completed

NCT00001518 - A Randomized Evaluation of the Effect of Routine Normal Saline Flush Versus Heparinized Saline Solution in Groshong and Groshong PICC Catheters

N/A

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT00073515
Study type	Interventional
Source	ARCA Biopharma, Inc.
Contact
Status	Completed
Phase	Phase 2

Trial of a Novel Fibrinolytic (Alfimeprase) to Clear Thrombosed Vascular Access Devices

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms